
Artificial intelligence in drug development - PubMed
Here we present an overview of recent advancements in AI applications across the entire drug development workflow, encompassing the identification of disease targets, drug discovery, preclinical and clinical studies, and post-market surveillance.
Artificial intelligence in drug development - Nature Medicine
2025年1月20日 · This Review explores the state-of-the-art applications of artificial intelligence in small-molecule drug development, from target identification and drug synthesis up to clinical trial design...
Here we present an overview of recent advancements in AI applications across the entire drug development workflow, encompassing the identification of disease targets, drug discovery,...
Dr. Lifeng Kang - Kang Lab
Lifeng Kang is a Senior Lecturer at the School of Pharmacy, Faculty of Medicine and Health, University of Sydney. His laboratory is focused on microscale technologies and 3D printing for drug delivery and tissue engineering. Dr. Kang has published 3 books, 5 book chapters, 69 peer-reviewed journal articles (56 as the main author), 81 abstracts
Lifeng Kang - Google Scholar
Associate Professor, School of Pharmacy, Faculty of Medicine and Health, University of Sydney - Cited by 4,423 - drug delivery - regenerative medicine - 3D printing. -...
Deep multiple instance learning on heterogeneous graph for drug…
2025年1月1日 · Deep Multiple Instance Learning is introduced in drug repositioning for the first time. Meta-path instances is elaborately designed and efficiently represented in proposed model MilGNet. MilGNet showed noteable improvements in 5 benchmarks compared with 8 baselines (10.9% on AUPR).
Fidele Ntie-Kang - ResearchGate
Current antiviral drug discovery efforts face many challenges, including development of new drugs during an outbreak and coping with drug resistance due to rapidly accumulating viral...
Congbao Kang - Principal Scientist - Experimental Drug …
Drug Discovery, EDDC A*STAR · Experienced Group Head with a demonstrated history of working in the research industry. Skilled in Structure Determination, Protein Structure, Membrane, Protein...
- 职位: Drug Discovery, EDDC A*STAR
- 位置: Experimental Drug Development Centre (EDDC)
- 500+ 连接数
Congbao KANG | Group Head | Ph.D. - ResearchGate
Small-molecule drugs are organic compounds affecting molecular pathways by targeting important proteins. These compounds have a low molecular weight, making them penetrate cells easily.
Application of Artificial Intelligence In Drug-target Interactions ...
2025年1月13日 · Kang et al. 42 (2022) utilized ProtBert, a BERT-based pre-trained model for amino acids, and RoBERTa pre-trained for encoding drug SMILES format, significantly enhancing performance in affinity...